Buscar
01/01/2022
A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial (vol 11, pg 187, 2021)
Abbruzzese, G, Kulisevsky, J, Bergmans, B, Gomez-Esteban, JC, Kagi, G, Raw, J, Stefani, A, Warnecke, T, Jost, WH. A European Observational Study to Evaluate the Safety and the Effectiveness of Safinamide in Routine Clinical Practice: The SYNAPSES Trial (vol 11, pg 187, 2021). Journal of Parkinsons Disease. 2022; 12(1)DOI:10.3233/JPD-219007. PMID:34275911. IF:5.200(Q1/3D).
01/01/2022
Functional changes in prefrontal cortex following frequency-specific training
Bach-Morrow L., Boccalatte F., DeRosa A., Devos D., Garcia-Sanchez C., Inglese M., Droby A.. Functional changes in prefrontal cortex following frequency-specific training. Scientific Reports. 2022; 12(1)DOI:10.1038/s41598-022-24088-7. PMID:36434008. IF:4.600(Q2/4D).
01/01/2022
Le risque de maladie de Parkinson dans une population méditerranéenne de patients goutteux : étude cas-témoins
Pou M.A., Orfila F., Pagonabarraga J., Ferrer-Moret S., Corominas H., Diaz-Torne C.. Le risque de maladie de Parkinson dans une population méditerranéenne de patients goutteux : étude cas-témoins. Revue Du Rhumatisme (edition Francaise). 2022; 89(6)DOI:10.1016/j.rhum.2022.09.019. PMID:. IF:(Q/D).
01/01/2022
Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert
Kulisevsky J.. Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert. REVISTA DE NEUROLOGIA. 2022; 75(s04)DOI:10.33588/rn.75s04.2022217. PMID:36342310. IF:1.200(Q4/10D).